vs

Side-by-side financial comparison of IM Cannabis Corp. (IMCC) and VerifyMe, Inc. (VRME). Click either name above to swap in a different company.

IM Cannabis Corp. is the larger business by last-quarter revenue ($9.3M vs $5.0M, roughly 1.8× VerifyMe, Inc.). IM Cannabis Corp. runs the higher net margin — -1.5% vs -66.7%, a 65.2% gap on every dollar of revenue. On growth, VerifyMe, Inc. posted the faster year-over-year revenue change (-7.4% vs -13.9%).

IM Cannabis Corp is a global cannabis enterprise focused on the cultivation, production, distribution and retail of medical and adult-use cannabis products. It runs business across core markets including North America, the European Union and Israel, offering branded cannabis goods, wellness derivatives and related consumer products to medical patients and recreational users.

VerifyMe, Inc. is a technology provider specializing in identity verification, anti-counterfeiting, and brand protection solutions. Its offerings include secure authentication tools, supply chain traceability systems, and customer engagement platforms, serving consumer goods, pharmaceutical, and retail sectors across North America and select global markets.

IMCC vs VRME — Head-to-Head

Bigger by revenue
IMCC
IMCC
1.8× larger
IMCC
$9.3M
$5.0M
VRME
Growing faster (revenue YoY)
VRME
VRME
+6.5% gap
VRME
-7.4%
-13.9%
IMCC
Higher net margin
IMCC
IMCC
65.2% more per $
IMCC
-1.5%
-66.7%
VRME

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
IMCC
IMCC
VRME
VRME
Revenue
$9.3M
$5.0M
Net Profit
$-141.6K
$-3.4M
Gross Margin
27.0%
41.2%
Operating Margin
-2.8%
-68.2%
Net Margin
-1.5%
-66.7%
Revenue YoY
-13.9%
-7.4%
Net Profit YoY
94.4%
-38.4%
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCC
IMCC
VRME
VRME
Q3 25
$5.0M
Q2 25
$9.3M
$4.5M
Q1 25
$4.5M
Q3 24
$5.4M
Q2 24
$10.8M
$5.4M
Q1 24
$5.8M
Q4 23
$8.7M
Q3 23
$5.6M
Net Profit
IMCC
IMCC
VRME
VRME
Q3 25
$-3.4M
Q2 25
$-141.6K
$-291.0K
Q1 25
$-571.0K
Q3 24
$-2.4M
Q2 24
$-2.5M
$-346.0K
Q1 24
$-553.0K
Q4 23
$2.0K
Q3 23
$-930.0K
Gross Margin
IMCC
IMCC
VRME
VRME
Q3 25
41.2%
Q2 25
27.0%
35.2%
Q1 25
33.4%
Q3 24
34.9%
Q2 24
5.7%
39.1%
Q1 24
39.2%
Q4 23
33.0%
Q3 23
36.5%
Operating Margin
IMCC
IMCC
VRME
VRME
Q3 25
-68.2%
Q2 25
-2.8%
-7.1%
Q1 25
-13.3%
Q3 24
-52.8%
Q2 24
-19.5%
-10.0%
Q1 24
-11.2%
Q4 23
0.8%
Q3 23
-15.3%
Net Margin
IMCC
IMCC
VRME
VRME
Q3 25
-66.7%
Q2 25
-1.5%
-6.4%
Q1 25
-12.8%
Q3 24
-44.6%
Q2 24
-23.4%
-6.5%
Q1 24
-9.6%
Q4 23
0.0%
Q3 23
-16.6%
EPS (diluted)
IMCC
IMCC
VRME
VRME
Q3 25
$-0.26
Q2 25
$-0.02
Q1 25
$-0.05
Q3 24
$-0.23
Q2 24
$-0.03
Q1 24
$-0.05
Q4 23
$0.00
Q3 23
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCC
IMCC
VRME
VRME
Cash + ST InvestmentsLiquidity on hand
$579.6K
Total DebtLower is stronger
Stockholders' EquityBook value
$3.0M
$11.1M
Total Assets
$30.0M
$13.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCC
IMCC
VRME
VRME
Q3 25
Q2 25
$579.6K
Q1 25
Q3 24
$2.6M
Q2 24
$511.0K
$2.9M
Q1 24
$2.8M
Q4 23
$3.0M
Q3 23
$2.9M
Total Debt
IMCC
IMCC
VRME
VRME
Q3 25
Q2 25
Q1 25
Q3 24
$500.0K
Q2 24
$600.0K
Q1 24
$800.0K
Q4 23
$875.0K
Q3 23
$1.0M
Stockholders' Equity
IMCC
IMCC
VRME
VRME
Q3 25
$11.1M
Q2 25
$3.0M
$14.4M
Q1 25
$14.6M
Q3 24
$10.3M
Q2 24
$4.0M
$12.3M
Q1 24
$12.4M
Q4 23
Q3 23
$11.9M
Total Assets
IMCC
IMCC
VRME
VRME
Q3 25
$13.3M
Q2 25
$30.0M
$17.2M
Q1 25
$17.1M
Q3 24
$14.8M
Q2 24
$29.4M
$17.5M
Q1 24
$17.9M
Q4 23
$20.7M
Q3 23
$18.8M
Debt / Equity
IMCC
IMCC
VRME
VRME
Q3 25
Q2 25
Q1 25
Q3 24
0.05×
Q2 24
0.05×
Q1 24
0.06×
Q4 23
Q3 23
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCC
IMCC
VRME
VRME
Operating Cash FlowLast quarter
$243.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCC
IMCC
VRME
VRME
Q3 25
$243.0K
Q2 25
$710.0K
Q1 25
$-404.0K
Q3 24
$-10.0K
Q2 24
$372.0K
Q1 24
$-60.0K
Q4 23
$843.0K
Q3 23
$-136.0K
Free Cash Flow
IMCC
IMCC
VRME
VRME
Q3 25
Q2 25
Q1 25
Q3 24
$-12.0K
Q2 24
$369.0K
Q1 24
$-62.0K
Q4 23
$840.0K
Q3 23
FCF Margin
IMCC
IMCC
VRME
VRME
Q3 25
Q2 25
Q1 25
Q3 24
-0.2%
Q2 24
6.9%
Q1 24
-1.1%
Q4 23
9.6%
Q3 23
Capex Intensity
IMCC
IMCC
VRME
VRME
Q3 25
Q2 25
Q1 25
Q3 24
0.0%
Q2 24
0.1%
Q1 24
0.0%
Q4 23
0.0%
Q3 23
0.0%
Cash Conversion
IMCC
IMCC
VRME
VRME
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
Q1 24
Q4 23
421.50×
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCC
IMCC

Segment breakdown not available.

VRME
VRME

Proactive Services$4.2M83%
Other$869.0K17%

Related Comparisons